Ra Pharmaceuticals Inc (RARX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARX | CLDX | DAWN | ||
| Company | Ra Pharmaceuticals Inc | Celldex Therapeutics | Day One Biopharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.99 | 34.51 | 21.50 | ||
| High | 48.01 | 34.90 | 21.53 | ||
| Low | 47.98 | 33.19 | 21.49 | ||
| Latest | 48.00 | 33.55 | 21.53 | ||
| Change | -0.02 | -0.66 | +0.04 | ||
| % Change | -0.03% | -1.93% | +0.19% | ||
| Volume | 3,864,600 | 727,127 | 2,988,800 | ||
| 20-Day Average Volume | 1,869,975 | 1,223,451 | 1,612,895 | ||
| Previous Close | 48.01 | 34.21 | 21.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 46.03 | 32.56 | 21.45 | ||
| 20-Day Raw Stochastic | 99.68% | 69.65% | 100.00% | ||
| 20-Day Relative Strength | 56.47 | 59.15 | 77.69 | ||
| Weighted Alpha | +21.70 | +54.71 | +69.84 | ||
| Today's Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.91% since 03/25/20 | -0.92% since 04/16/26 | +0.28% since 04/15/26 | ||
| Low | 46.34 on 03/26/20 | 33.19 on 04/23/26 | 21.45 on 04/16/26 | ||
| High | 48.02 on 03/31/20 | 35.79 on 04/20/26 | 21.53 on 04/22/26 | ||
| 1-Month | |||||
| %Chg | +2.64% since 02/28/20 | +5.50% since 03/23/26 | +0.42% since 03/20/26 | ||
| Low | 40.30 on 03/18/20 | 28.41 on 04/02/26 | 21.34 on 03/24/26 | ||
| High | 48.02 on 03/31/20 | 35.79 on 04/20/26 | 21.53 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +2.27% since 12/31/19 | +29.44% since 01/23/26 | +74.47% since 01/22/26 | ||
| Low | 40.30 on 03/18/20 | 22.33 on 02/06/26 | 9.97 on 03/03/26 | ||
| High | 48.02 on 03/31/20 | 35.79 on 04/20/26 | 21.53 on 04/22/26 | ||
| 6-Month | |||||
| %Chg | +112.27% since 10/01/19 | +27.76% since 10/23/25 | +196.56% since 10/22/25 | ||
| Low | 22.25 on 10/08/19 | 22.10 on 11/11/25 | 6.90 on 10/30/25 | ||
| High | 48.02 on 03/31/20 | 35.79 on 04/20/26 | 21.53 on 04/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,271,555 | 2,277,223 | 2,224,781 | ||
| Shares Outstanding, K | 47,329 | 66,566 | 103,334 | ||
| Annual Sales | 3,000,000 | 1,550,000 | 158,180,000 | ||
| Annual Net Income | -102,690,000 | -258,760,000 | -107,320,000 | ||
| Last Quarter Sales | 3,000,000 | 120,000 | 53,720,000 | ||
| Last Quarter Net Income | -24,980,000 | -81,320,000 | -21,280,000 | ||
| 60-Month Beta | 1.04 | 1.19 | -1.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.22 on 02/25/26 | -0.20 on 02/24/26 | ||
| Latest Earnings Date | 05/14/20 | 05/14/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||